M&G plc’s Acadia Healthcare ACHC Stock Holding History

M&G plc’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-419,416	Closed	-$9.65M	–	372
2025 Q2	$9.65M	Buy	+419,416	New	+$9.94M	0.05%	211

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

M&G plc's ACHC Position: Q3 2025 in Review

M&G plc sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 419,416 shares — an estimated $9.65M sold.

M&G plc first reported a position in ACHC in Q2 2025 and held it in 1 quarter. The position peaked at $9.65M in Q2 2025. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

M&G plc reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
M&G plc sold 419,416 Acadia Healthcare shares in Q3 2025, an estimated $9.65M.
M&G plc first reported a position in Acadia Healthcare in Q2 2025 and held it in 1 quarter.
M&G plc's Acadia Healthcare position peaked at $9.65M in Q2 2025.
270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on M&G plc's 13F filing for Q3 2025, filed 7 Nov 2025.